ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Estrogen Can Benefit Women With Metastatic Breast Cancer

January 30, 2009

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

Bush Increase For NIH In Sharp Contrast To Cuts In Health Delivery Programs.

April 6, 2001

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

Swedish Study Finds Long Term Hormonal Therapy May Increase Breast Cancer Risk

August 4, 1989